Scientific distinctions between coca and cocaine support policy reform Ongoing review of international drug policy should correct long-standing, misguided, and harmful conflation
Fecha de publicación:
By Dawson M. White, Ricardo Soberón Garrido, Caroline S. Conzelman, Wade Davis, Claude Guislain, Anthony Henman, Orlando Adolfo Jara-Muñoz, Martin Jelsma, Susana Mejía, Daniel Montoya-Cataño, Oscar Alejandro Pérez-Escobar, David Alfonso Restrepo, Kenny Alejandra Saavedra-Rojas, and Imikita Tariiru.
Published in Science on 15 October 2025, this peer-reviewed article examines the pharmacological, cultural, and policy distinctions between coca leaf and cocaine. The authors argue that these differences support evidence-based reform of international drug control frameworks and correction of long-standing misclassifications.
Read the article in Science (Open access for two weeks).
Author copy available here on Harvard DASH.
Creditos
Mas como esto
-
Reconsidering Coca Leaf Scheduling: TNI Statement to the WHO-ECDD
Fecha de publicación:
-
WHO Critical Review of Coca Leaf A Comprehensive Overview
Fecha de publicación:
